Pfizer Boasts of ‘Blockbuster’ Profits from Treating Turbo Cancer Surge – EVOL

Pfizer CEO Albert Bourla has gloated that his pharmaceutical company is expecting to reap “blockbuster” profits from treating the global surge in turbo cancers among the Covid-vaccinated.

Since Covid mRNA shots were rolled out to the public in early 2021, cases of rapidly developing cancers in young, healthy people have skyrocketed.

Oncologists and leading doctors around the world have been raising the alarm about the issue.

Many are reporting that patients who appear healthy are often dead within a week of being diagnosed.

The rapid onset of the disease has led to experts dubbing the phenomenon “turbo cancer.”

Evidence has continued to mount to suggest that the global turbo cancer epidemic is directly linked to Covid mRNA shots.

Many scientists have pointed to the DNA fragment contamination in the injections as the cause of the cancers.

However, the devastating impact is not bad news for everyone, apparently.

According to Pfizer CEO Albert Bourla, skyrocketing cancer cases present an opportunity to make “blockbuster” profits.

Celebrating these new opportunities, Bourla gloated that cancer “is our new Covid.”

The Big Pharma boss made the claims during a new interview with Fox Business where he discussed Pfizer’s recent acquisition of cancer treatment company



Subscribe to Our Free Newsletter